Elevated fetal adipsin/acylation-stimulating protein (ASP) in obese pregnancy: Novel placental secretion via hofbauer cells

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 10, 2013, Pages 4113-4122

  Sivakumar, K ^b   Bari, M F ^b   Adaikalakoteswari, A ^b   Guller, S ^c   Weickert, M O ^b   Randeva, H S ^b   Grammatopoulos, D K ^b   Bastie, C C ^b,d   Vatish, M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION STIMULATING PROTEIN; CHOLESTEROL; COMPLEMENT FACTOR D; FATTY ACID; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTROPHOBLAST; EXPLANT; FEMALE; FIBROBLAST; GLUCOSE BLOOD LEVEL; HOFBAUER CELL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; OBESITY; PLACENTA; PLACENTA CIRCULATION; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; UMBILICAL CORD BLOOD; UNIVERSITY HOSPITAL;

ADIPOSE TISSUE; ADULT; BODY COMPOSITION; BODY MASS INDEX; COMPLEMENT FACTOR D; FEMALE; FETAL BLOOD; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; OBESITY; PLACENTA; PREGNANCY;

EID: 84885192283     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4293     Document Type: Article

References (44)

1. Finkelstein EA, Khavjou OA, Thompson H, Trogdon J.G., Pan L., Sherry B, Dietz W. Obesity and severe obesity forecasts through 2030. Am J Prev Med. 2012; 42: 563-570.
2. Heslehurst N, Rankin J, Wilkinson J.R., Summerbell CD A nationally representative study of maternal obesity in England, UK: trends in incidence and demographic inequalities in 619 323 births, 1989-2007. Int J Obes (Lond). 2010; 34: 420-428.
3. Sebire NJ, Jolly M, Harris J.P., et al Maternal obesity and pregnancy outcome: a study of 287, 213 pregnancies in London. Int J Obes Relat Metab Disord. 2001; 25: 1175-1182.
4. Dennedy MC, Avalos G, O'Reilly MW, O'Sullivan EP, Gaffney G, Dunne F. ATLANTIC-DIP: raised maternal body mass index (BMI) adversely affects maternal and fetal outcomes in glucose-tolerant women according to International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. J Clin Endocrinol Metab. 2012; 97: E608-E612.
5. Boney CM, Verma A, Tucker R., Vohr BR Metabolic syndrome in childhood: association with birth weight, maternal obesity, and ges-tational diabetes mellitus. Pediatrics. 2005; 115: e290-e296.
6. Dabelea D, Hanson RL, Lindsay R.S., et al Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000; 49: 2208-2211.
7. Akcakus M, Kurtoglu S, Koklu E., Kula M, Koklu S. The relationship between birth weight leptin and bone mineral status in newborn infants. Neonatology. 2007; 91: 101-106.
8. Briana DD, Malamitsi-Puchner A. The role of adipocytokines in fetal growth. Ann NY Acad Sci. 2010; 1205: 82-87.
9. Cripps RL, Martin-Gronert MS, Ozanne SE Fetal and perinatal programming of appetite. Clin Sci (Lond). 2005; 109: 1-11.
10. Cook KS, Min HY, Johnson D, et al Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science. 1987; 237: 402-405.
11. Zhu L, Wigle D, Hinek A., et al The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin. J Clin Invest. 1994; 94: 1163-1171.
12. White RT, Damm D, Hancock N., et al Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem. 1992; 267: 9210-9213.
13. Takeshita A, Kondo T, Okada T., Kusakabe KT Elevation of adipsin, a complement activating factor, in the mouse placenta during spontaneous abortion. J Reprod Dev. 2010; 56: 508-514.
14. Maslowska M, Vu H, Phelis S., et al Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest. 1999; 29: 679-686.
15. Baldo A, Sniderman AD, St Luce S, et al The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest. 1993; 92: 1543-1547.
16. Cianflone K, Maslowska M, Sniderman A. The acylation stimulating protein-adipsin system. Int J Obes Relat Metab Disord. 1995; 19(SUPPL. 1): S34-S38.
17. Cianflone K, Roncari DA, Maslowska M, Baldo A., Forden J, Sniderman AD. Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry. 1994; 33: 9489-9495.
18. Millar CA, Meerloo T, Martin S., et al Adipsin and the glucose transporter GLUT4 traffic to the cell surface via independent pathways in adipocytes. Traffic. 2000; 1: 141-151.
19. Murray I, Sniderman AD, Cianflone K. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice. Am J Physiol. 1999; 277: E474-E480.
20. Yasruel Z, Cianflone K, Sniderman A.D., Rosenbloom M., Walsh M, Rodriguez MA Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids. 1991; 26: 495-499.
21. Van Harmelen V., Reynisdottir S, Cianflone K., et al Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. J Biol Chem. 1999; 274: 18243-18251.
22. Germinario R, Sniderman AD, Manuel S, Lefebvre S.P., Baldo A., Cianflone K. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. Metabolism. 1993; 42: 574-580.
23. Cianflone K, Xia Z, Chen LY Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta. 2003; 1609: 127-143.
24. Faraj M, Beauregard G, Tardif A., et al Regulation of leptin, adiponectin and acylation-stimulating protein by hyperinsulinaemia and hyperglycaemia in vivo in healthy lean young men. Diabetes Metab. 2008; 34: 334-342.
25. Saleh J, Cianflone K, Chaudhary T., Al-Riyami H, Al-Abri AR, Bayoumi R. Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation. Obesity (Silver Spring). 2007; 15: 646-652.
26. Saleh J, Al-Riyami HD, Chaudhary T.A., Cianflone K. Cord blood ASP is predicted by maternal lipids and correlates with fetal birth weight. Obesity (Silver Spring). 2008; 16: 1193-1198.
27. Siman CM, Sibley CP, Jones C.J., Turner MA, Greenwood SL The functional regeneration of syncytiotropho blast in cultured explants of term placenta. Am J Physiol Regul Integr Comp Physiol. 2001; 280: R1116-R1122.
28. Tan BK, Chen J, Lehnert H., Kennedy R, Randeva HS Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab. 2007; 92: 2764-2772.
29. Gould PS, Gu M, Liao J., et al Upregulation of urotensin II receptor in preeclampsia causes in vitro placental release of soluble vascular endothelial growth factor receptor 1 in hypoxia. Hypertension. 2010; 56: 172-178.
30. Schneider CA, Rasband WS, Eliceiri KW NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9: 671-675.
31. Tang Z, Tadesse S, Norwitz E., Mor G, Abrahams VM, Guller S. Isolation of Hofbauer cells from human term placentas with high yield and purity. Am J Reprod Immunol. 2011; 66: 336-348.
32. Matthews DR, Hosker JP, Rudenski A.S., Naylor BA, Treacher DF, Turner RC Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-419.
33. Hendrickse W, Stammers JP, Hull D. The transfer of free fatty acids across the human placenta. Br J Obstet Gynaecol. 1985; 92: 945-952.
34. Challier JC, Basu S, Bintein T., et al Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta. 2008; 29: 274-281.
35. Haghiac M, Vora NL, Basu S, et al Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obesity. 2012; 20: 2213-2219.
36. Xia Z, Cianflone K. Acylation-stimulating protein precursor proteins in adipose tissue in human obesity. Metabolism. 2003; 52: 1360-1366.
37. Cianflone K, Maslowska M. Differentiation-induced production of ASP in human adipocytes. Eur J Clin Invest. 1995; 25: 817-825.
38. Black MH, Sacks DA, Xiang A.H., Lawrence JM The relative contribution of prepregnancy overweight and obesity, gestational weight gain, and IADPSG-defined gestational diabetes mellitus to fetal overgrowth. Diabetes Care. 2013; 36: 56-62.
39. In: Rasmussen KM, Yaktine AL, eds. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC, National Academies Press; 2009.
40. Fain JN, Nesbit AS, Sudlow F.F., et al Release in vitro of adipsin, vascular cell adhesion molecule 1, angiotensin 1-converting enzyme, and soluble tumor necrosis factor receptor 2 by human omental adipose tissue as well as by the nonfat cells and adipocytes. Metabolism. 2007; 56: 1583-1590.
41. Cianflone K, Zakarian R, Couillard C., Delplanque B, Despres JP, Sniderman A. Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. J Lipid Res. 2004; 45: 124-131.
42. Yang Y, Lu HL, Zhang J, et al Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Int J Obes (Lond). 2006; 30: 439-446.
43. Schrauwen P, Hesselink MK, Jain M, Cianflone K. Acylation-stimulating protein: effect of acute exercise and endurance training. Int J Obes (Lond). 2005; 29: 632-638.
44. Wen Y, Wang H, MacLaren R., Wu J, Lu H, Cianflone K. Palmitate and oleate induction of acylation stimulating protein resistance in 3T3-L1 adipocytes and preadipocytes. J Cell Biochem. 2008; 104: 391-401.